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Abstract
Introduction: Prevention of mother-to-child transmission (PMTCT) has the potential to eliminate new HIV infections among
infants. Yet in many parts of sub-Saharan Africa, PMTCT coverage remains low, leading to unacceptably high rates of morbidity
among mothers and new infections among infants. Intimate partner violence (IPV) may be a structural driver of poor PMTCT
uptake, but has received little attention in the literature to date.
Methods: We conducted qualitative research in three Johannesburg antenatal clinics to understand the links between IPV and
HIV-related health of pregnant women. We held focus group discussions with pregnant women (n13) alongside qualitative
interviews with health care providers (n10), district health managers (n10) and pregnant abused women (n5). Data were
analysed in Nvivo10 using a team-based approach to thematic coding.
Findings: We found qualitative evidence of strong bidirectional links between IPV and HIV among pregnant women. HIV
diagnosis during pregnancy, and subsequent partner disclosure, were noted as a common trigger of IPV. Disclosure leads to
violence because it causes relationship conflict, usually related to perceived infidelity and the notion that women are ‘‘bringing’’
the disease into the relationship. IPV worsened HIV-related health through poor PMTCT adherence, since taking medication or
accessing health services might unintentionally alert male partners of the women’s HIV status. IPV also impacted on HIV-related
health via mental health, as women described feeling depressed and anxious due to the violence. IPV led to secondary HIV risk
as women experienced forced sex, often with little power to negotiate condom use. Pregnant women described staying silent
about condom negotiation in order to stay physically safe during pregnancy.
Conclusions: IPV is a crucial issue in the lives of pregnant women and has bidirectional links with HIV-related health. IPV may
worsen access to PMTCT and secondary prevention behaviours, thereby posing a risk of secondary transmission. IPV should be
urgently addressed in antenatal care settings to improve uptake of PMTCT and ensure that goals of maternal and child health are
met in sub-Saharan African settings.
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Introduction
Prevention of mother-to-child transmission (PMTCT) has
reduced new infant HIV infections from an estimated 32% in
the absence of treatment [1,2], to as low as 1% [3,4]. However,
major gaps in achieving PMTCTcoverage remain. In 21 priority
African countries, PMTCTcoverage is estimated to be 65% [5].
A recent meta-analysis in low- and middle-income settings
suggests that while 75% of pregnant women adhere to anti-
retroviral therapy (ART) during pregnancy, only 53% maintain
adequate adherence levels in the postpartum period [6].
Ensuring PMTCT adherence is crucial, particularly as countries
increasingly move towards ‘‘Option B,’’ a policy that offers
immediate, lifelong treatment for pregnant women living with
HIV [7].
Many structural drivers influence PMTCT uptake and
adherence. The literature has noted that structural factors
such as stigma [813], poverty [11] and transport costs [10]
inhibit women’s ability to adhere to PMTCT. Another key
structural factor shaping access and adherence to PMTCTmay
be intimate partner violence (IPV). Fear and experience of IPV
influence pregnant women’s decisions to take up HIV services
[14,15], and anticipated violence is associated with declines in
HIV testing among pregnant women [12,1622]. A history of
physical or sexual violence decreases the likelihood of HIV-
positive women using ART when medically eligible [23,24],
and those who experience abuse are more likely to miss clinic
visits and delay linkage to care [25].
Little research to date has explored the association between
IPV and PMTCT. In one qualitative study in South Africa, IPV
was described as a common barrier to ART adherence in
pregnancy [11]. Healthy intimate partner relationships im-
prove PMTCT uptake: male involvement in antenatal care
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predicted better adherence to nevirapine in one South African
study [26]; male antenatal attendance halved the risk of MTCT
in a Kenyan study, an association that persisted after control-
ling for maternal viral loads [27].
Using qualitative research methodology, we explored IPV as
a potential structural driver of HIV-related health among preg-
nant women. This research aimed to contribute to literature
suggesting that structural drivers shape the health and well-
being of those already living with HIV, andmay pose barriers to
uptake of proven prevention strategies.
Methods
We conducted qualitative research to explore the links bet-
ween IPV and HIV-related health among pregnant women and
service providers in Johannesburg, South Africa. This research
was a portion of a larger formative study, intended to help our
team design an intervention to address IPV in pregnancy. In
this setting, an estimated 29% of pregnant women are HIV
positive [28] and between 25 and 35% experience physical or
sexual IPV in the 12 months leading up to pregnancy [2932].
Conceptual framework
To explore the relationship between IPV and HIV-related
health of pregnant women, we used an adapted socio-
ecological conceptual framework (Figure 1), which posits that
broader structural factors and relationship characteristics
influence a woman’s HIV-related health [33]. This type of
approach has been embraced by social scientists, who note
that broader social and societal factors shape how women
are able to adhere to ART [34] and the extent to which they
experience IPV [35]. A socio-ecological framework highlights
that the structural context influences the conditions and
health outcomes of both IPV and HIV.
Data collection
We conducted an exploratory qualitative study using in-depth
interviews (IDIs) and focus group discussions (FGDs) with
a wide range of stakeholders with the potential to take
part in, deliver, or scale-up an intervention for violence in
pregnancy. Participants included pregnant women, pregnant
women experiencing IPV, health workers, non-governmental
organizations, community leaders and policy makers (Table 1).
Pregnant women seeking antenatal care from two antena-
tal clinics were recruited for four FGDs (a total of n13
women participated). Women were given group information
about the study while they waited in queue for a clinic
appointment. All FGDs were conducted in a private room in
the clinic, led by trainedmoderators whowere the same sex as
participants and fluent in multiple local languages (Sotho,
Zulu, Tswana). Semi-structured discussion guides explored
several topics (Table 1). Discussions were audio-recorded after
obtaining participants’ permission and signing an informed
consent form. The discussion groups lasted for about 1 hour
and 30 minutes, and women were reimbursed R50 (US $6).
Because of the nature of focus groups, additional confiden-
tiality measures were implemented: during the informed
consent process, researchers explained that questions about
women’s individual experiences of violence or HIV would not
be asked, but rather the discussion would address the issue as
observed in the community.
Pregnant women who were experiencing IPV were identi-
fied during the FGDs. Trained researchers explained that
those women who had personal experience of IPV and were
interested in participating in IDIs could approach the research
team outside of the information giving session and privately
indicate their interest in taking part in an interview. The
interviews (n5) took place in a private room at the clinics
while the pregnant women were still waiting to be seen by
clinic staff. As shown in Table 1, the topics explored through
structured interview guides were more focused on IPV-
related help seeking and the relationship between IPV and
HIV. On average, these interviews lasted about 60 minutes.
In depth interviews withOther Key Stakeholderswere led by
the research team and covered similar topics. This group
comprised policy makers (n10), health workers (n8), non-
governmental organizations (n6) and community-based
organizations (n4). Stakeholder interviews focused on
service provision and asked questions about available re-
sources for women experiencing IPV. Some anecdotes of cases
were shared, but this was not the main rationale for these
interviews.
Several steps were taken to ensure confidentiality and
provide additional support for participants during the re-
search. In keeping with ethical considerations of researching
IPV in pregnancy, all researches were conducted based on the
World Health Organization’s guidance on ethical and safety
considerations in researching violence against women [36].
Study staff were trained to describe research as the ‘‘social
barriers’’ to use health services in the community, so as to
reduce any undue risk associated with participating in a
violence-related study. All participants were offered an
information sheet containing contact information of local
resources (counselling, legal advice and health care). Given the
high prevalence of IPV in South Africa, it was likely that
participants in categories other than ‘‘pregnant and experien-
cing IPV’’ category had experienced or witnessed IPV. If any
individual demonstrated a need for additional assistance, that
individual was offered an opportunity to speak to someoneFigure 1. Conceptual framework.
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about his or her experience of IPV, and given referrals
to organizations that could assist him or her. However, no
participants asked for this referral during the course of the
formative research.
All participation in this formative research was sought
on the basis of informed consent and good clinical prac-
tice guidelines. Ethics approval was obtained by the World
Health Organization (WHO A65780) and University of the
Witwatersrand (HREC M110832).
Data analysis
The interview and FGD data were transcribed verbatim in the
language in which they were conducted and, as necessary,
translated from the local language (Sotho, Zulu, Tswana) into
English by professional translators. To ensure accurate trans-
lation, each transcript was reviewed by a researcher, and
queries were resolved through discussions among the re-
searchers via phone or email. All identifying information about
the participant or clinic setting was removed and transcripts
were saved by a file name with no personal details.
Data were managed in QSR Nvivo 10, a qualitative analysis
software package, following a two-day qualitative manage-
ment and analysis training of the research team. Members of
the research team collaboratively built an analytical frame-
work of broad codes by creating a ‘‘start list’’ of possible
themes and building upon the research questions. Each broad
code, or wide thematic basket of ideas [37], was applied to
each transcript by two researchers using NVivo. The research
team then held a series of meetings to collectively develop
‘‘fine codes’’ using an inductive approach  deriving meaning
from the data itself rather than imposing pre-formed ideas
[38]. Fine codes were developed by printing out a full set of
excerpts (from each database) related to each code and
identifying sub-themes emerging from the data.
Results
We found qualitative evidence of strong bidirectional links
between IPV and HIV among pregnant women. Here, we
present a conceptual framework (Figure 2) for understanding
the ways in which IPV is related to HIV-related health of
pregnant women.
Pathway 1: HIV diagnosis leads to IPV via partner disclosure
HIV diagnosis during pregnancy was noted to be a trigger of
IPV. One pregnant woman described how severe violence
began following disclosure of her HIV-positive status during
pregnancy:
He started telling me things, hurting me emotionally,
telling me that I’m a fool, and stupid, I’m an idiot.
And then he strangled me, That’s when it started . . .
Maybe it’s pregnancy, I don’t know. I told him that
I am HIV positive, so I don’t know if that’s what
made him to do all these things.  Pregnant abused
woman 1
HIV may lead to violence because it causes relationship
conflict during the disclosure process. Usually, the conflict is
Table 1. Data collection methods
Participant group Group size Method Sampling Example participants Topics
Pregnant women
at ANC
n13
women in 4
FGDs
Focus group
discussions
Convenience  Social and structural drivers of IPV; types of IPV
in pregnancy; patterns of help seeking and
available community resources for violence and
HIV; barriers to disclosing IPV; receptivity to an
antenatal intervention
Pregnant abused
women
n5 Semi-
structured
interviews
Convenience  Existing needs and concerns of abused women;
patterns of help seeking and available
community resources for violence; links
between IPV and HIV; receptivity to an
antenatal intervention
Policy makers n10 Semi-
structured
interviews
Purposive Department of Health
managers, academic
experts
Types of IPV in pregnancy; current health sector
response to IPV; potential integration with HIV
activities, including PMTCT
Health providers n8 Semi-
structured
interviews
Purposive Doctors, nurses, lay
counsellors in antenatal
clinics
Types of IPV in pregnancy; knowledge and
practice responding to IPV; receptivity of health
workers to antenatal intervention; existing
capacity in clinic
Non-governmental
organizations
n6 Semi-
structured
interviews
Purposive Shelters, police, counselling
services
Psycho-social, legal and other needs of abused
women; referral options for women living
with IPV
Community
leaders
n4 Semi-
structured
interviews
Convenience Pastors, neighbourhood
representatives, traditional
healer
Community factors that support or prevent
women from seeking IPV assistance during
pregnancy
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related to perceived infidelity and blaming women for
‘‘bringing’’ the disease into the relationship:
Yes, if you’re HIV positive, you start blaming each
other. Because maybe the husband will be saying
the wife brought it. So sometime, there’s a connec-
tion [between HIV and violence] because you end up
blaming each other.  Pregnant woman, FGD 3
Because HIV testing is coupled with antenatal care, women
often learn of their HIV status in a clinic during access to
health care during pregnancy.Within this health care context,
women bear the brunt of disclosure to partners, who tend to
use women’s status as a ‘‘proxy’’ for their own.
In addition to physical violence, pregnant women de-
scribed experiencing emotional abuse and abandonment
following disclosure of HIV to a partner:
I have a sister, she was pregnant, . . . then she came
to be tested. When she tested she found out she is
positive, and when she told her boyfriend every-
thing turned around. And there was violence at
home. He started coming late and when she started
asking for things for her and the baby, he started
to react badly up until he ended up leaving her.
 Pregnant woman, FGD 2
Within a context where women fear violence, blame and
abandonment, it is perhaps not surprising that many
pregnant women chose not to disclose their HIV status to
partners. Several pregnant women spoke about the fear of
partner disclosure when women live in violent relationships:
Women who are in this abusive relationship, they do
get HIV and they are scared what their partner will
say.  Pregnant abused woman 1
Health workers talked about how women in violent relation-
ships would be hesitant to disclose their status to partners:
When you counsel them . . . after they have tested
positive and when you have to issue the treatment
she’ll be saying, ‘I am not going to disclose. I mustn’t
take this, I must hide it’. Then you find out is it a
problem for her to disclose because there’s some
emotional abuse or physical abuse from the partner.
 Female Health Worker 4
Thus, fear of partner disclosure may be an early warning sign
that pregnant women are in violent or unsupportive relation-
ships and require additional assistance during antenatal care.
Pathway 2: IPV worsens HIV-related health via
non-adherence
For women in violent relationships, adherence to PMTCT
services was challenging, since taking medication or acces-
sing health services might unintentionally alert male partners
of their HIV status.
Health workers noted that non-adherence also served
as warning sign that HIV-positive patients were in a violent
relationship:
Figure 2. IPV and HIV-related health among pregnant women.
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It was the very same patient that you had told she
was HIV positive that was scared to go and disclose
to their partner. It is the very same patient that will
default on their medication because their partner
does not know that they are taking the medication.
 Policy Maker 9
In the antenatal clinic, an HIV diagnosis in the context of
living with violence may cause patients to default on clinic
visits:
But in your normal facility it is a bit difficult to avoid
losing patients. I think we do. Especially the mere
fact that you say to a patient, ‘‘you are HIV positive.’’
And this is a patient who is facing domestic
violence! Some will just disappear.  Policy maker 3
Thus, the fear of being identified by a male partner as being
HIV positive may preclude women from returning to clinic
services that are essential for their health. While no partici-
pants mentioned this directly, it is important to note that non-
adherence to PMTCT regimens greatly increases the risk that
pregnant or breastfeeding women will transmit HIV to the
infant.
Pathway 3: IPV worsens HIV-related health via mental
health
Declines in mental health were noted in women experiencing
IPV in pregnancy. In response to persistent violent relation-
ships, women described internalizing the abuse and assum-
ing that they had done something wrong to deserve it:
He used to beat her while she was pregnant. She
just accepted it, and sometime she’d blame herself.
Saying maybe I’m the one who’s wrong that’s why
he’s beating me.  Pregnant woman, FGD 1
Although IPV is associated with common mental health
disorders in pregnancy, few patients or providers recognized
these as having clinical implications. Most health providers
equated mental health to severe cases of psychopathology
and said they rarely encountered mental health disorders.
For example, one health worker only considered mental
health in relation to bipolar depression and pharmacologi-
cally treated patients:
Mental health, yes, I remember we’ve had three
that we already on treatment, and will tell you, I
have a bipolar patient.  Health worker 8
We found that health workers often fail to notice the mental
health dynamics of IPV in pregnancy, choosing instead to
focus on physical health sequelae of pregnancy. For example,
one health provider was asked about stress related to IPV, but
responded only in terms of how stress impacts hypertension
while ignoring the relevant impact on a woman’s mental
health:
Stress is one of the predisposing factors to the
development of hypertension. So it is still there, this
stress, but as a predisposing factor. Sometimes
because of the pregnancy itself, you can develop
hypertension of pregnancy.  Health worker 6
This tendency towards equating mental health with severe
illness may be related to the lack of capacity within South
Africa’s public health system. As one policy maker explained,
in overlooking mental health issues, current health systems
make it unlikely that patients will receive the crucial support
that they require:
No one has time for mental health because there
are so many other crises in the health system that
need to be addressed, that are much more mani-
fested. So that means that things like depressive
disorder or mental health disorders, they’re not
addressed  including partner depression, mental
health and abuse and all of that. And people are not
really encouraged to go and get support that they
require.  Policy Maker 9
The notion of overlooking mental health is illustrated in an
interview with one pregnant, abused woman when she
described severe physical violence as leading to a state of
being ‘‘a little depressed’’:
Interviewer (I): Are you enjoying your pregnancy so
far?
Participant (P): Being honest, a little depressed but
I’m enjoying it.
I: Ok, so the depression is from what, if I may ask?
P: From the father of the baby. We are having
problems.
I: What did he do, if you don’t mind telling me.
P: He strangled me and then he let his cousin beat
me up.  Pregnant abused woman 1
Not everyone in our sample ignored the impact of mental
health on a woman’s health and wellbeing. For example, poor
mental health had concomitant effects on physical health
for one HIV-positive participant, who described ‘‘going low’’
emotionally because of violence, and thereafter feeling
worse physically:
I’m HIV positive and I’m in this domestic violence.
And if you are HIV positive and then you have a
partner who is abusing you emotionally . . . or
physically hits you, people can’t talk. Maybe you
can go low, maybe you can go sick.  Pregnant
abused woman 3
Pathway 4: IPV leads to secondary HIV risk via lack of
relationship control
IPV led to secondary HIV risk when women were in rela-
tionships with forced sex or without power to negotiate
condom use.
When we are in relationships where our partner
is abusive, sometimes we can’t even negotiate
things like using the condom. Let’s say, for instance,
you know that your partner is the kind of person
that has other girlfriends, but because he uses
power over you, you can’t negotiate those things.
 Pregnant woman, FGD 4
Male partners used their control over the relationship to
dictate the terms and timing of sexual activity. In one
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instance, a FGD revealed a story about a newly diagnosed
HIV-positive woman whose partner insisted that she have sex
without condoms:
There’s a friend of mine that was tested alone and
she had a lot of problems. The man said, I’m not HIV
positive, so I’m not going to test. So the man forced
her to sleep with him without a condom. And that
man said ‘No! Why? We’ve been sleeping with
out a condom, but because today you went to the
clinic, you’re telling me we’ve to use a condom?’
 Pregnant woman, FGD 1
Pregnant women described balancing risks to physical safety
(absence of physical harm to themselves or foetus) with
health risks (of onwards HIV transmission to partners). They
described making compromises between protecting them-
selves and the foetus and protecting themselves and partners
from sexually transmitted infections:
If you are not compromising at all and you start
saying ‘‘let’s use condom,’’ he’ll start having ques-
tions. Some things are better left unsaid, just for the
safety part of it.  Pregnant woman, FGD 2
Many preferred staying silent on condom negotiation, in
order to stay physically safe during pregnancy.
Discussion
We found that IPV and HIV-related health were connected
concerns in the lives of pregnant women in Johannesburg. IPV
and HIV seemed to have distinct pathways linking them to
one another within the context of pregnancy. The initial HIV
disclosure could serve as a trigger for violence in pregnancy.
IPV, in turn, worsened HIV-related health through key path-
ways of lack of adherence and poor mental health. Finally, the
experience of IPV led to secondary transmission risk beha-
viours  both in terms of vertical transmission due to PMTCT
non-adherence or secondary transmission due to risky sex.
According to our participants, IPV shapes HIV-related health
outcomes among pregnant women primarily because it leads
to non-adherence. While the effect of IPV on adherence has
been confirmed in small studies in the United States [3943],
this association is yet to be explored among pregnant women.
Pregnant and postpartum women are a crucial population
within which to understand IPV and adherence, since non-
adherence leads not only to morbidity and mortality of the
woman but also to risk of onwards HIV transmission to her
infant [3,4]. Antenatal care provides a crucial moment to
enable adherence, since a pregnant woman accesses the
health system routinely and this is when many are first
diagnosed with HIV.
Poor adherence among pregnant women may relate to
challenges around partner disclosure [44]. In a recent sys-
tematic review of PMTCT, partner disclosure was associated
with poor PMTCT uptake in a majority of both quantitative
(6 of 9) and qualitative (17 of 24) studies [45]. We found that
partner disclosure following HIV diagnosis in pregnancy led to
enacted or feared violence. This aligns with extant literature,
which suggests that fear of new or continued IPV may lead
women to avoid disclosure of their status to male partners [11].
In one Nigerian study among HIV-positive pregnant women,
the prevalence of IPV was 17% before HIV testing and
increased to 63% after testing for HIV and disclosing status
[46]. A Zimbabwean study showed that the risk of IPV in
pregnancy was greatest among those women testing positive
for HIV in antenatal care [47]. Non-disclosure among pregnant
women is a health risk in its own right, since it poses a risk for
sexual transmission of HIV if the male partner is still HIV
negative [4851] andmay have an impact on the implementa-
tion of PMTCT [52].
A related but distinct pathway linking IPV to PMTCT uptake
may be mental health. A growing body of literature shows
that IPV leads to depression and anxiety among pregnant
women [29,53,54], yet this link has been largely unexplored in
sub-Saharan Africa in HIV-positive populations. Our findings
reflect those of a qualitative study in Zambia, in which IPV,
mental health and HIV are closely related in the experience of
women [55]. Such interrelated ‘‘syndemic’’ issues [56] should
be explored in future sub-Saharan African studies.
Existing research shows poor mental health has significant
impact on ART adherence [5760] and among pregnant
women depressive symptoms are associated with HIV disease
progression and mortality [61]. It is possible that IPV is one
condition exacerbating the relationship between mental
health and HIV outcomes. Indeed, one new study suggests
that the link between mental health and ART adherence may
be partly driven by partner conflict [62]. Despite high rates of
common mental health disorders in antenatal care [63], little
screening or treatment exists in South Africa [64]. Mental
health will be crucial to address among HIV-positive pregnant
women because of its strong relationship to IPV and its
association with the uptake of PMTCT regimens [65].
Finally, IPVmay worsen secondary prevention behaviours in
pregnancy. Non-adherence to PMTCT regimens greatly in-
creases the risk that pregnant or breastfeeding women will
transmit HIV to the infant [66], potentially in drug-resistant
form [67]. High viral loads related to non-adherence also
increase the likelihood of secondary transmission to partners,
particularly in the context of unsafe sex. Our research reflects
existing knowledge by suggesting that IPV inhibits women’s
ability to negotiate condoms [68]. These findings explore such
dynamics within the context of pregnancy, thereby suggesting
a dual risk of mother-to-child infection and secondary trans-
mission risk to a partner.
Our findings echo calls for addressing IPV in pregnancy [69].
Scholars note that antenatal care provides an important
‘‘window of opportunity’’ for women who are regularly ac-
cessing the health system [70]. Although universal screening is
not recommended in settings with limited referral options and
overstretched providers [71], some type of IPV assessment,
provider training and targeted response may be appropriate
for South African antenatal care. Indeed, a comprehensive
health response to IPV will likely require either screening or
case-finding  both methods that may be acceptable in South
African clinics [72,73].
Limitations
The findings of this formative research should be examined in
light of several limitations. Firstly, this study is exploratory in
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nature, resulting in small sample sizes of each participant
group. While analysis suggested that we began to reach
saturation through FGDs with pregnant women, the IDIs with
pregnant women experiencing IPV were not sufficient to
reach thematic saturation [74]. Secondly, the socio-ecological
perspective was brought to the data analysis process after
data collection. Ideally, this conceptual approach would have
informed the entire data collection process, rather than
simply guiding the final interpretation of findings. However,
since this was a preliminary, exploratory study, it was
designed to explore several intersecting issues and we applied
the conceptual framework during data analysis. Finally, some
of the findings may be applicable for any woman experiencing
IPV, and do not necessarily highlight the specific context of
pregnancy. Further research should explore the perinatal
time-period in detail to determine whether the link between
IPV and HIV is somehow distinct during this life stage.
Conclusions
IPV in pregnancy leads to declines in the physical and mental
health of pregnant women. Our findings underscore the
negative effects of IPV as a health issue in its own right and
as a barrier to PMTCT. The connection between IPV and HIV
medication adherence among pregnant women has yet
to be explored quantitatively in sub-Saharan Africa. In future
studies, it would be ideal to find systematic methods for
recruiting more robust numbers of pregnant women who
experience IPV and who are living with HIV. In the parent
study [75], we anticipate that by training health providers to
ask about IPV confidentially and skilfully, it may be increas-
ingly possible to reach this crucial population.
Beyond its marked impact on physical and mental health
of women, IPV in pregnancy may have important implications
for Option B, as current cost-effectiveness models assume
that women are willing and able to achieve 100% adherence
[76]. If Option B is to be adopted more broadly, the effect
of IPV on adherence and mental health should be carefully
considered. Addressing the inter-related issues of violence
and HIV will be crucial to ensure that goals of maternal and
child health are met in the sub-Saharan African region.
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